Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Nevo, IL
Dornon Nevo, Ra'Anana IL
| Patent application number | Description | Published |
|---|---|---|
| 20110170159 | LIGHT LIMITING WINDOW - A passive optical power limiting window comprising a transparent optical input element, a transparent optical output element, and a power-limiting element disposed between these input and output elements for transmitting optical light from these input elements to these output elements, these optical power-limiting elements comprising an optical-limiting solid mixture containing particles of at least one material that produces reversible thermal changes in response to light above a predetermined optical power level, thereby changing the optical transmission properties of these power-limiting elements. | 07-14-2011 |
Doron Nevo, Ra'Ananna IL
| Patent application number | Description | Published |
|---|---|---|
| 20080212312 | Lice Extermination System and Method - Apparatus ( | 09-04-2008 |
Eviatar Nevo, Haifa IL
| Patent application number | Description | Published |
|---|---|---|
| 20080248020 | Heparanases and Splice Variants Thereof, Ponucleotides Encoding Them and Uses Thereof - The invention relates to novel heparanases, heparanase splice variants, and to polynucleotides encoding them. Particularly, the invention relates to | 10-09-2008 |
| 20080263729 | Stress Tolerant Organisms Expressing a Map Kinase Homologue - The present invention provides a MAP kinase homologue gene, designated EhHOG, isolated from | 10-23-2008 |
Inbar Nevo, Tel-Aviv IL
| Patent application number | Description | Published |
|---|---|---|
| 20110097771 | ISOLATED POLYNUCLEOTIDES AND POLYPEPTIDES AND METHODS OF USING SAME FOR INCREASING PLANT UTILITY - Provided are isolated polypeptides comprising the amino acid sequence at least 80% homologous to SEQ ID NO:68, 51-66, 69-100, 379-656, 707-715, 720-723, 742-754, 764-771 or 772 with the proviso that the amino acid sequence is not as set forth by SEQ ID NO: 765 or 771, isolated polynucleotides comprising the nucleic acid sequence at least 80% identical to SEQ ID NOs:18, 1-16, 19-50, 101-378, 657-672, 674-706, 716-719, 724-741 and 755-763 with the proviso that the nucleic acid sequence is not as set forth by SEQ ID NO:756 or 762, and isolated polynucleotides selected from the group consisting of SEQ ID NOs:779-792 and methods of using same for increasing oil content, yield, growth rate, biomass, vigor, abiotic stress tolerance and/or nitrogen use efficiency of a plant. | 04-28-2011 |
Moti Nevo, Rosh Ha'Ain IL
| Patent application number | Description | Published |
|---|---|---|
| 20110252451 | PERSONAL TV GATEWAY STB/ROUTER - A method for routing TV content including using a personal TV gateway STB/router to route a first TV content to a first TV receiver located in a first location in a home, while simultaneously routing a second TV content to a second TV receiver located in a second location in the home, and commanding the personal TV gateway STB/router to transfer the first TV content from the first TV receiver in the first location to a mobile personal communication device, while still controlling routing the second TV content to the second TV receiver located in the second location. | 10-13-2011 |
Ron Nevo, Misgav IL
| Patent application number | Description | Published |
|---|---|---|
| 20100022242 | IDLE MODE HANDLING IN A HYBRID GSM/CDMA NETWORK - In a mobile wireless telecommunications system, which includes base stations ( | 01-28-2010 |
Shlomo Nevo, Tel-Aviv IL
| Patent application number | Description | Published |
|---|---|---|
| 20080272148 | Self Contained Foam Dispenser - A self-contained foam dispensing device includes a casing, a mixing chamber, a port adapted to receive one or more containers including a plurality of chemicals in a plurality of compartments and a flow generator adapted to induce flow of chemicals from the compartments toward a mixing chamber, the flow generator being located between the mixing chamber and the port. When the one or more containers are in the port the one or more containers move with movement of the casing. | 11-06-2008 |
| 20090266840 | Substance Injecting Apparatuses and Methods for Using Same - A chemical injection system, comprising: a drive mechanism; a housing removably attached to the drive mechanism; at least one chemical inlet located on the housing; and, a valve spool located within the housing and provided with at least one chemical pass-through port, wherein the drive mechanism rotates the valve spool to align the chemical pass-through port with the chemical inlet. | 10-29-2009 |
| 20100098571 | Pump Apparatus and Methods for Using Same - A pump apparatus for transporting at least one fluid, comprising a shaft, wherein the shaft has a longitudinal axis; a motor, wherein the motor is adapted to rotate the shaft about the longitudinal axis; and, a plurality of gerotors, wherein the gerotors are attached to the shaft along the longitudinal axis and wherein the shaft rotation actuates the plurality of gerotors rotation, causing pumping of the at least one fluid. | 04-22-2010 |
| 20110155762 | FOAM DISPENSER NOZZLE - A chemical mixing device. The device includes a flow generator operative to provide at least two streams of chemicals and a mixing chamber, including at least two inlets adapted to receive the at least two streams of chemicals and an outlet through which a mixture of the streams of chemicals is ejected from the mixing device. The mixing chamber has an open state in which the chemicals are mixed and a closed state in which the volume of the mixing chamber is less than a fifth of the open state volume. | 06-30-2011 |
| 20110210120 | APPARATUS AND METHOD FOR DELIVERING A PRODUCT INTO A RECEPTACLE - An apparatus for delivering a product into a receptacle having a feeding aperture. The apparatus comprises a mixing chamber having a plurality of inlets each configured for separately receiving at least one of a plurality of component materials and at least one outlet, the mixing chamber being configured for forming the product by mixing the plurality of component materials and injecting the product to the feeding aperture via the at least one outlet and a feeding element configured for being secured in a feeding channel for allowing the injecting. | 09-01-2011 |
Yaniv Nevo, Ness-Ziona IL
| Patent application number | Description | Published |
|---|---|---|
| 20110306035 | Methods and Compositions for Detection of a Pathogen, Disease, Medical Condition, or Biomarker Thereof - Provided are methods for detecting the presence or absence of a pathogen, disease, or medical condition, or biomarker thereof, using an enzymatic activity assay. In one embodiment, the method provided utilizes competitive inhibition of an enzyme for detecting a pathogen, disease, or medical condition, or biomarker thereof, in a subject. The method comprises providing a biological sample from the subject that may or may not contain an endogenous substrate. A test reaction is provided by contacting the biological sample with an enzyme indicative of the biomarker of a pathogen, disease, or medical condition and a substrate comprising a signaling moiety. The enzyme modifies the endogenous substrate and the substrate comprising the signaling moiety. Modification of the substrate comprising the signaling moiety by the enzyme produces a signal from the signaling moiety. Data from a control reaction comprising the enzyme and the substrate comprising the signaling moiety is further provided. The signal produced by the signaling moiety in the test reaction is detected. The presence of the biomarker of the pathogen, disease, or medical condition is indicated by a difference caused by the presence of the endogenous substrate in the biological sample between the signal produced in the test reaction and the data from the control reaction. In another embodiment, there is provide a method of detecting the presence or absence of enzymatic activity in a biological sample indicative of a pathogen, disease, or medical condition, or biomarker thereof, in a subject. The method comprises contacting a biological sample obtained from a subject that may or may not contain an enzyme with a substrate of the enzyme to be detected. The substrate comprises a signaling molecule such that when the enzyme is present in the biological sample, the enzyme modifies the substrate and the signaling moiety emits a signal, indicating the presence of a pathogen, disease, or a medical condition, or a biomarker thereof, in the subject. | 12-15-2011 |
Yoad Nevo, Tel Aviv IL
| Patent application number | Description | Published |
|---|---|---|
| 20110081025 | EFFICIENT FILTER FOR ARTIFICIAL AMBIENCE - A circuit, method, and system for producing artificial ambience effect for an input audio signal, mono, stereo, or surround. The ambience effect enhances artificial reverberation, replaces artificial reverberation, or synthesizes extra audio channels, such as surround channels. The circuit may include a transient reduction module and a reverberation filter. The transient reduction module may be adapted to reduce transients in an input audio signal of one or more channels. The reverberation filter maybe adapted to receive a transient-reduced signal of one or more channels corresponding to the transient-reduced signal. | 04-07-2011 |
Yoav Nevo, Kochav Yair IL
| Patent application number | Description | Published |
|---|---|---|
| 20090306639 | Cryoprobe incorporating electronic module, and system utilizing same - A cryotherapy system comprises a cryoprobe comprising, for example, either an electronic module including a memory or a response module operable to respond to a query signal with a response signal. A communications interface uses these modules to establish a unique identification of the cryoprobe, and a control module regulates delivery of cryogen to the cryoprobe according to calculations at least partially based on stored data associated with that unique cryoprobe identification. | 12-10-2009 |
Yoram Nevo, Tel Aviv IL
| Patent application number | Description | Published |
|---|---|---|
| 20110053853 | USE OF COPOLYMER 1 FOR TREATMENT OF MUSCULAR DYSTROPHY - The invention provides an active agent selected from the group consisting of Copolymer 1, a Copolymer 1 related-peptide and a Copolymer 1-related polypeptide, or a pharmaceutically acceptable salt thereof, and pharmaceutical compositions comprising the active agent, for use in treating a muscular dystrophy disease or disorder. | 03-03-2011 |
Ziv Nevo, Yoneam Ilit IL
| Patent application number | Description | Published |
|---|---|---|
| 20090326886 | Formal Verification of Models Using Concurrent Model-Reduction and Model-Checking - Formal verification of models using concurrent model-reduction and model-checking. For example, a system for formal verification of models includes: one or more model reducers to reduce a model; one or more model checkers to check the model, wherein at least one of the model reducers is to run concurrently with at least one of the model checkers; and a model synchronizer to synchronize information between at least one of the model reducers and at least one of the model checkers. | 12-31-2009 |
Ziv Nevo, Haifa IL
| Patent application number | Description | Published |
|---|---|---|
| 20110022373 | MODEL CHECKING OF LIVENESS PROPERTY IN A PHASE ABSTRACTED MODEL - Phase abstraction may be utilized to increase efficiency of model checking techniques. A liveness property may be checked in respect to a phase abstracted model by modifying the liveness property in accordance with the phase abstracted model. A fairness property may be modified to ensure that the fairness property is held by the model checker. A counter-example produced by a model checker is modified to be in accordance to an original model. The counter-example comprises a repetitive behavior. The counter-example may be modified to shorten the repetitive behavior or to apply the repetitive behavior in an earlier cycle of the counter-example. | 01-27-2011 |
| 20110071809 | MODEL GENERATION BASED ON A CONSTRAINT AND AN INITIAL MODEL - A model may comprise finite paths in respect to a constraint. The model and the constraint may be modified such that a portion of the limitations induces by the constraint is injected to the model. Adding the limitation directly to the model may be expressed by a reduction of a measurement of nondeterminism in the model. The model may be modified based on the constraint, and the constraint may be modified based on the model. The constraint may be strengthened to provide for an early finite path detection. | 03-24-2011 |
Ziv Nevo, Yokneam IL
| Patent application number | Description | Published |
|---|---|---|
| 20100185992 | System for Quickly Specifying Formal Verification Environments - Computer-implemented techniques are disclosed for defining an environment for formal verification of a design-under-test. Initially there is extraction of design inputs by a design analysis module, and presentation of the inputs on a graphical user interface. Behavior options for the design inputs are offered on the graphical user interface for selection by an operator. Environment code that is descriptive of the design inputs and selected behavior options is emitted, typically in a hardware description language, for submission to a formal verification tool. A meta-code file containing the assigned behavior options is generated to aid subsequent sessions. | 07-22-2010 |
Ziv Nevo, Yokneam Ilit IL
| Patent application number | Description | Published |
|---|---|---|
| 20110144958 | DETECTION OF DESIGN REDUNDANCY - Augmented-domain simulation, such as ternary-based simulation may be utilized to approximate a reachability analysis of a model being model checked. The approximated reachability analysis may be utilized to detect design redundancies and modify the model to remove such redundancies. Design redundancies may include unobservable variables, mergeable variables and utilization of surplus domains. | 06-16-2011 |
Zvi Nevo, Herzlia IL
| Patent application number | Description | Published |
|---|---|---|
| 20090004276 | Novel injectable chitosan mixtures forming hydrogels - A chitosan composition which forms a hydrogel at near physiological pH and 37° C., comprising at least one type of chitosan having a degree of acetylation in the range of from about 30% to about 60%, and at least one type of chitosan having a degree of deacetylation of at least about 70% is disclosed. Further disclosed is a chitosan composition which forms a hydrogel at near physiological pH and 37° C., comprising at least one type of chitosan having a degree of deacetylation of at least about 70% and a molecular weight of from 10-4000 kDa, and at least one type of a chitosan having a molecular weight of from 200-20000 Da. Further disclosed are methods of preparation and uses of the chitosan compositions. | 01-01-2009 |
| 20090192119 | Inhibition of the Renin-Angiotensin System for the Treatment of Renal, Vascular and Cartilage Pathology - A method of treating a disease or condition in which up-regulating GAGs is therapeutically beneficial is disclosed. The method comprises locally administering to a subject a therapeutically effective amount of an agent capable of down-regulating activity or expression of a component of the renin-angiotensin system. | 07-30-2009 |
| 20110104225 | POLYPEPTIDES, MATRICES, HYDROGELS AND METHODS OF USING SAME FOR TISSUE REGENERATION AND REPAIR - A novel laminin polypeptide comprising the amino acid sequence set forth by SEQ ID NO:3 is disclosed. Also disclosed are compositions-of-matter comprising a polysaccharide (e.g., hyaluronic acid) and the novel laminin polypeptide; or hyaluronic acid, a laminin polypeptide and an antioxidant (e.g., superoxide dismutase), as well as matrices and hydrogels comprising same which can be used for ex vivo or in vivo tissue formation and for treatment of pathologies characterized by diseased, damaged or loss of tissue. | 05-05-2011 |
| 20110230411 | Albumin fibers and fabrics and methods of generating and using same - Provided are method of generating a fiber from a globular protein such as albumin. Also provided are albumin fibers and fabrics and methods of using same for bonding a damaged tissue or for ex vivo or in vivo formation of a tissue. | 09-22-2011 |